| |
⇐Home → Planning → 2008 → HIV/AIDS Fact Sheets
→ HISPANIC/LATINOS, SUBSTANCE USE, AND HIV/AIDS
|
| |
|
| |
HISPANIC/LATINOS, SUBSTANCE USE, AND HIV/AIDS
Since the
beginning of the HIV/AIDS epidemic, injection drug use (IDU) has directly and
indirectly accounted for more than one-third (36%) of AIDS cases in the U.S.[1]
At the end of 2006, an estimated
353,825 male adults and adolescents were living with HIV/AIDS, 17% had been
exposed through injection drug use and 7% had been exposed through both
male-to-male sexual contact together with intravenous drug use.[2] A
greater proportion of IDU-associated HIV/AIDS cases occur among adolescent and
adult women. Of the estimated 131,195 female adults and adolescents living with
HIV/AIDS, 26% had been exposed through injection drug use.[3] A significant number of women diagnosed with
HIV/AIDS in 2006 were infected through high risk heterosexual contact with a
male who was infected with a history of intravenous drug use.
IDU-associated
HIV/AIDS disproportionately affects Latino communities in the U.S. At the end
of 2006 in 33 states with confidential name-based reporting, 14,427 male adult
or adolescent Hispanics living with HIV/AIDS became infected through injecting
drugs with HIV contaminated needles, representing 23% of Hispanic males living
with HIV/AIDS.[4] Latino
males become HIV positive through IDU more often than other communities in the U.S.—IDU was the primary mode of transmission
for 22% of African American males living with HIV/AIDS and 9% of non-Hispanic
White males living with HIV/AIDS in the U.S.[5]
The burden of IDU-associated HIV/AIDS is even greater for Latinas. Approximately
5,528 female adult or adolescent Latinas living with HIV/AIDS accounted for
IDU-associated HIV/AIDS cases, representing 28% of Hispanic females living with
HIV/AIDS at the end of 2006.[6]
This statistic is alarming because the rate of IDU-associated transmission
among Latinas climbed from the previous year’s rate—in 2005, Latina women
represented 25% of the IDU reported HIV/AIDS cases.[7]
According to the
National Institute of Drug Abuse, behavior associated with drug and alcohol use
is now the single largest factor in the spread of HIV infection in the U.S.[8] Alcohol
use is associated with multiple risk factors for exposure to HIV infection, especially
among youth, including risky sexual behaviors such as having multiple sexual
partners and inconsistent condom use.[9] [10]
Among students who were currently sexually active in 2005, 25.6% of
Hispanic/Latino students reported drinking alcohol or using drugs before last
sexual intercourse, compared with 25.0% of white students and 14.1% of black
students.[11]
Drug use through injection and
methods of drug delivery in general increases the risk for HIV transmission
because of the tendency to engage in risky sexual behaviors while under the
influence of a substance and the practice of sharing of needles or other injection
equipment.[12]
Substance users who share injection equipment—syringes, cookers, water and
cotton—while injecting or splitting drugs are at a higher risk for HIV
infection and other STIs.[13]
Unprotected sexual activity is a high risk factor for men and especially women
with IDU male partners.[14]
Another way people may be at risk for HIV is simply by using drugs—regardless
of whether a needle and/or syringe are involved. Users of non-injection drugs
(such as some forms of crystal meth or cocaine use) are also more likely to be
exposed to HIV infection—according to a CDC study, crack smokers are three 3
times more likely to be infected with HIV than non-smokers.[15]
Risk also varies depending on drug use; for example, methamphetamine increases
sexual desire and has been shown to lead to unsafe sex.[16]
Methamphetamine
(Crystal Meth) and HIV Risk Among Latino MSM
The increased
use of methamphetamine amongst population subgroups in the U.S. raises concern.
Methamphetamine is a highly addictive stimulant that affects the nervous system
with a high potential for abuse and psychological or physical dependence.[17]
The drug can be taken orally, by snorting, by needle injecting, or by smoking.[18]
Among those who inject the drug, HIV and other sexually transmitted infections
can be spread through sharing HIV contaminated needles, syringes, and other
shared injection equipment. However, the drug also has the dangerous affect of
altering behavior, judgment, and inhibition, making methamphetamine
non-injection drug users more prone to high-risk taking behavior for HIV
transmission. MSM methamphetamine users report an increased number of sexual
partners, decreased use of condoms, multiple-partner sexual activities,
engaging in sex with casual and anonymous partners, engaging in unprotected
receptive and insertive anal sex with casual partners, an increased likelihood
of being HIV-infected or having a sexually transmitted infection, and an
increased likelihood of contracting hepatitis A, B or C infection.[19] Studies
of HIV positive methamphetamine users demonstrate that there is a strong
association between methamphetamine use and risky sexual behavior for
contacting HIV and other STIs.[20] A
recent study of 19,000 men in Los Angles showed that new HIV infections were
three times higher among methamphetamine users than among nonusers.[21]
In the U.S.,
methamphetamine use is a significant problem among urban MSM. Methamphetamine
and other “party” drugs (such as ecstasy) are used by MSM as a means to
decrease social inhibitions and enhance sexual experiences.[22]
These drugs, along with alcohol have been strongly associated with risky sexual
practices among MSM.[23] MSM methamphetamine users report an increased
number of sexual partners, decreased use of condoms, multiple-partner sexual
activities, engaging in sex with casual and anonymous partners, engaging in
unprotected receptive and insertive anal sex with casual partners, an increased
likelihood of being HIV-infected or having a sexually transmitted infection,
and an increased likelihood of contracting hepatitis A, B or C infection.[24]
Until recently
methamphetamine was perceived as a problem of the White MSM community and not
for Latino MSM. However, recent studies show methamphetamine use among Latino
gay men is similar to white gay men.[25]
According to research done by the
Cesar Chavez Institute in California, which
studied Latino gay men in San
Francisco (N=300), crystal meth was the most
frequently used drug.[26] It was used monthly or more frequently
among 50% of the studied population. In a 2005 survey of a larger
group of Latino gay men (N=2,000+) in San
Francisco, 15% of these Latino gay men reported using
methamphetamine.[27]
According to the authors: "Latino gay men were found to rely on
methamphetamine for reasons related to sexual enhancement, possibly to meet
cultural expectations and norms of sexual prowess and sexual success in the gay
community".[28] In the
same study, the authors found that the majority of methamphetamine use was
found among Latino men who were recruited from the internet chat rooms, with
two-thirds reporting methamphetamine use in the last six months.[29]
Approximately 72% of Latino gay men who use methamphetamine report at least one
instance of unprotected anal intercourse within a period of 6 months.[30]
This is the highest HIV risk rate ever reported for any Latino MSM group
studied.[31]
Despite this alarming fact, there are not nearly enough
campaigns that are culturally appropriate for Hispanic methamphetamine users.
There is a critical need for crystal meth prevention and treatment programs
designed by Latinos rather than just translated programs designed for White
non-Hispanic MSM.[32]
Estimated Proportion of AIDS Cases
Associated with Injection Drug Use, by Transmission Category Diagnosed in 2006—United States
and Dependent Areas[33]
**NOTE: US Dependent Areas include American Samoa,
Guam, the Northern Mariana Islands, Puerto Rico, and the U.S. Virgin Islands**

[1] Centers for Disease Control. “Fact Sheet:
Drug-Associated HIV Transmission Continues in the United States”. Atlanta: Department of Health and Human
Services, Centers for Disease Control and Prevention, 2002. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2006report/pdf/2006SurveillanceReport.pdf
[2] Centers for Disease Control. “Surveillance Report
2006”. Atlanta, GA: Department of Health and Human Services,
Centers for Disease Control and Prevention. 2006. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2006report/pdf/2006SurveillanceReport.pdf
[3] Centers for Disease Control. “Surveillance Report
2006”. Atlanta, GA: Department of Health and Human Services,
Centers for Disease Control and Prevention. 2006.
[4] Centers for Disease Control. “Surveillance Report
2006”. Atlanta, GA
: Department of Health and Human Services,
Centers for Disease Control and Prevention. 2006. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2006report/pdf/2006SurveillanceReport.pdf
[5] Centers for Disease Control. “Surveillance Report
2006”. Atlanta, GA: Department of Health and Human Services,
Centers for Disease Control and Prevention. 2006.
[6] Centers for Disease Control. “Surveillance Report
2006”. Atlanta, GA
: Department of Health and Human Services,
Centers for Disease Control and Prevention. 2006. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2006report/pdf/2006SurveillanceReport.pdf
[7] Centers for Disease Control. “CDC HIV/AIDS
Surveillance Report, 2005”. Atlanta,
GA: Department of Health and
Human Services, Centers for Disease Control and Prevention. 2005.
http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2005report/
[8] National Institute
of Drug Abuse (NIDA).
“Infofacts: Drug Abuse and AIDS”.
http://www.nida.nih.gov/Infofacts/DrugAbuse.html
[9] Shier, LA et al. “Temporal associations between
depressive symptoms and self-reported sexually transmitted disease among
adolescents”. Arch Pediatr Adolesc Med 156:599-606. 2002.
[10] Mitchell, CM et al. “Alcohol use, outcome
expectancies, and HIV risk status among American Indian Youth: A Latent Growth
Curve Model with Parallel Processes”. Journal of Youth and Adolescence, vol.
35(5), p. 726-737, 2006.
[11] Centers for Disease Control. “Youth risk behavior
surveillance—United States,
2005”. MMWR 55(SS-5); 1-108, 2006.
[12] Centers for Disease Control. “Fact Sheet:
Drug-Associated HIV Transmission Continues in the United States”. Atlanta: Department of Health and Human
Services, Centers for Disease Control and Prevention, 2002.
http://www.cdc.gov/hiv/resources/Factsheets/idu.htm
[13] Centers for Disease Control. “Access to sterile
syringes”. Atlanta, GA:
Department of Health and Human Services, Centers for Disease Control and
Prevention, National
Center for HIV, STD and
TB Prevention, 2005. http://www.cdc.gov/idu/facts/aed_idu_acc.htm
[14] Kral AH, Bluthenthal RN, Lorvick J, et al. “Sexual
transmission of HIV-1 among injection drug users in San Francisco, USA:
risk-factor analysis”. Lancet.
2001: Vol. 357, pp1397-1401.
[15] Centers for Disease Control. “Fact Sheet:
Drug-Associated HIV Transmission Continues in the United States”. Atlanta: Department of Health and Human
Services, Centers for Disease Control and Prevention, 2002.
[16] Bull SS, Piper P, Rietmeijer C. “Men who have
sex with men and also inject drugs-profiles of risk related to the synergy of
sex and drug injection behaviors”. Journal of Homosexuality. 2002;42:31-51.
[17] Centers for Disease Control. “Factsheet:
Methamphetamine Use and Risk for HIV/AIDS”. 2007.
[18] National Institute on Drug Abuse. “NIDA: InfoFacts”.
National Institutes of Health,
US Department
of Health and Human Services.
[19] UCLA Integrated Substance Abuse Programs. “Special Populations: Men who have sex with men”.
2006. http://www.methamphetamine.org/html/special-pops-MSM.html
[20] Molitor, F. et al. “Association of Methamphetamine Use
During Sex with Risky Sexual Behaviors and HIV Infection Among Non-Injection
Drug Users”. West J Med: 1998, Vol
168 (2), pp 93-7.
[21] Sherry, L. “HIV Risk Behaviors Among Gay Male
Methamphetamine Users: Before and After Treatment”. Journal of Gay &
Lesbian Psychotherapy: 2006, Vol 10 (3/4).
[22] Mansergh G, Colfax GN, Marks G, et al. The Circuit
Party Men’s Health Survey: findings and implications for gay and bisexual men. American
Journal of Public Health 2001;91:953–958.
[23] Purcell DW, Parsons JT, Halkitis PN, Mizuno Y, Woods
WJ. Substance use and sexual transmission risk behavior of HIV-positive men who
have sex with men. Journal of Substance Abuse 2001;13:185–200.
[24] UCLA Integrated Substance Abuse Programs. “Special Populations: Men who have sex with men”.
2006. http://www.methamphetamine.org/html/special-pops-MSM.html
[25]
Accion Mutua. “Methamphetamine Use and HIV Risk Among
Latino Gay Men”. http://www.apla.org/accionmutua/resources/other/broadsheet_pdf/MethBroadsheet53106.pdf
[26]Diaz, Rafael et al. “Fabulous
Effects/Disastrous Consequences: Stimulant use among Latino gay men in San Francisco” Cesar
Chavez Institute Study, 2004.
[27] Diaz, RM et al. “Reasons for Stimulant Use Among
Latino Gay Men in San Francisco:
A comparison between methamphetamine and cocaine users”. Journal of Urban
Health, 2005, Vol. 82(1), pp. 71-78.
[28] Diaz, RM et al. “Reasons for Stimulant Use Among
Latino Gay Men in San Francisco:
A comparison between methamphetamine and cocaine users”. Journal of Urban
Health, 2005, Vol. 82(1), pp. 71-78.
[29] Diaz, RM et al. “Reasons for Stimulant Use Among
Latino Gay Men in San Francisco:
A comparison between methamphetamine and cocaine users”. Journal of Urban
Health, 2005, Vol. 82(1), pp. 71-78.
[30] Accion Mutua. “Methamphetamine Use and HIV Risk Among
Latino Gay Men”. http://www.apla.org/accionmutua/resources/other/broadsheet_pdf/MethBroadsheet53106.pdf.
[31] Accion Mutua. “Methamphetamine Use and HIV Risk Among
Latino Gay Men”. http://www.apla.org/accionmutua/resources/other/broadsheet_pdf/MethBroadsheet53106.pdf
[32] Latino Commission on AIDS. “Crystal Methamphetamine
and Latinos in New York City;
One Organization’s Perspective”. New
York, NY.
http://www.latinoaids.org/crystalmeth/crystalmethreport.pdf
[33] Centers for Disease Control. “AIDS Surveillance:
General Epidemiology: Estimated Number and Proportion of AIDS Cases Associated
with Injection Drug Use, by Transmission Category Diagnosed in 2006—United States
and Dependent Areas : Slide 17”. Atlanta:
Department of Health and Human Services, Centers for Disease Control and
Prevention, 2006. http://www.cdc.gov/hiv/topics/surveillance/resources/slides/epidemiology/index.htm
|
| |
|
|
|
|